Fulcrum Therapeutics, INC. (FULC) — SC 13G/A Filings
All SC 13G/A filings from Fulcrum Therapeutics, INC.. Browse 13 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (13)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 4, 2024
- SC 13G/A Filing — Oct 7, 2024
- SC 13G/A Filing — Sep 16, 2024
- SC 13G/A Filing — Aug 23, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 13, 2024
-
FMR LLC & Abigail Johnson Maintain 9.195% Stake in Fulcrum Therapeutics
— Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Fulcrum Therapeutics, Inc. (FULC) through a -
Adage Capital Partners Cuts Fulcrum Therapeutics Stake to 1.9%
— Feb 7, 2024
Adage Capital Partners, L.P. filed an amended SC 13G/A on February 7, 2024, disclosing its ownership in Fulcrum Therapeutics, Inc. As of December 31, 2023, Adag
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX